ADVERTISEMENT

Bradley J. Monk, MD

Bradley Monk, MD, University of Arizona School of Medicine

Videos

Mirvetuximab Soravtansine for Folate Receptor-Alpha High, Platinum-Resistant Ovarian Cancer

08/02/2023

Bradley J. Monk , MD;

Bradley Monk, MD, discusses the results from the phase 3 MIRASOL trial and shares insights about mirvetuximab soravtansine for folate receptor-alpha high, platinum-resistant ovarian cancer.

Bradley Monk, MD, discusses the results from the phase 3 MIRASOL trial and shares insights about mirvetuximab soravtansine for folate receptor-alpha high, platinum-resistant ovarian cancer.

Bradley Monk, MD, discusses the...

08/02/2023

Oncology

Bradley Monk, MD

Conference Coverage

Front-Line Treatment Options for Ovarian Cancer

12/07/2023

Bradley J. Monk , MD;

At the Great Debates & Updates in Women’s Oncology meeting, Bradley Monk, MD, discussed molecular testing and advancements in front-line treatment for patients with advanced epithelial ovarian cancer.

At the Great Debates & Updates in Women’s Oncology meeting, Bradley Monk, MD, discussed molecular testing and advancements in front-line treatment for patients with advanced epithelial ovarian cancer.

At the Great Debates & Updates...

12/07/2023

Oncology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

See Full Calendar

Advertisement

Advertisement